General Experimental Information Commercially available chemical reagents, purchased from Sigma-Aldrich, Alfa Aesar, TCI and ACROS, were used as received without further purification. All solvents were distilled before usage and moisture-sensitive reactions were performed under nitrogen atmosphere. Analytical thin-layer chromatography (TLC) was performed using silica gel coated aluminum plates with a thickness of 0.2 mm (Macherey-Nagel). The compounds were visualized with a potassium permanganate stain solution containing 1.50 g KMnO 4 , 10.0 g K 2 CO 3 and 100 mg NaOH in 200 mL H 2 O. Liquid column chromatography purification was performed with silica gel 60 (40-63 μm mesh, Macherey-Nagel). Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker Avance III HD 400 at 295 K. Chemical shifts (δ) are given in parts per million (ppm) with respect to the solvent residual proton signals (δ(CDCl 3 ) = 7.26 ppm, δ(CD 3 OD) = 3.31 ppm) for 1 H or the resonance signals (δ(CDCl 3 ) = 77.16 ppm, δ(CD 3 OD) = 49.00 ppm) for 13 C. Coupling constants (J) are reported in Hertz (Hz) and the multiplicity is abbreviated as s (singlet), d (doublet), t (triplet), m (multiplet), dd (doublet of doublets), br d (broad doublet) etc. Signal assignment was performed with additional information of DEPT135, ( 1 H, 1 H)-COSY, ( 1 H, 13 C)-HSQC and ( 1 H, 13 C)-HMBC. Atom numbers do not refer to the IUPAC nomenclature. High resolution mass spectrometry (HRMS) was performed with a Bruker Daltonics micrOTOF-Q III (electrospray ionization, ESI) instrument.
Chemical synthesis of ω-azido-sphingosine

Experimental Procedures
tert-Butyl ((2S,3R,E)-18-bromo-1-((tert-butyldimethylsilyl)oxy)-3-hydroxyoctadec-4en-2-yl)carbamate (3)
To a solution of allylic alcohol 1 (2.00 g, 6.03 mmol, 1.00 eq.) and alkene 2 (6.98 g, 24.1 mmol, 4.00 eq.) in dry CH 2 Cl 2 (50 mL) was added Grubbs catalyst 2 nd generation (154 mg, 181 μmol, 0.03 eq.) at rt. The reaction mixture was stirred at 50°C for 2 h. The solvent was removed under reduced pressure and the residue was purified by column chromatography on silica gel (CyH:EtOAc, 1:0 to 9:1 v/v) to give 3 (1.80 g, 3 .03 mmol, 50 %) as a colourless, waxy solid. Chemical synthesis of ω-azido-sphingosine tert-Butyl ((2S,3R,E)-18-azido-1-((tert-butyldimethylsilyl)oxy)-3-hydroxyoctadec-4-en-2-yl)carbamate (4) To a solution of bromide 3 (1.00 g, 1.69 mmol, 1.00 eq.) in DMF (20 mL) was added NaN 3 (329 mg, 5.06 mmol, 3.00 eq.). The reaction mixture was stirred at 70°C for 18 h, cooled to rt and then H 2 O (100 mL) was added. After the extraction with EtOAc (5 x 30 mL), the combined organic phases were washed with brine (20 mL) and dried (MgSO 4 : δ 155.9 (C-1'), 133.2 (C-5), 129.6 (C-4), 79.5 (C-2'), 74.8 (C-3), 63.6 (C-1), 54.6 (C-2), 51.6 (C-18), 32.4 (C-6), 29.8, 29.7, 29.7, 29.6, 29.6, 29.3, 29.3, 26.8 (overall 10C, C-7-16), 29.0 (C-17), 28.5 (3C, C-3'), 25.9 (3C, C-3''), 18.2 (C-2''), −5.5 (C-1''), −5.5 (C-1''); HRMS (m/z): [M+Na] + calcd. for C 29 H 58 N 4 NaO 4 Si, 577.4120; found, 577.4126.
Chemical synthesis of ω-azido-sphingosine
tert-Butyl ((2S,3R,E)-18-azido-1,3-dihydroxyoctadec-4-en-2-yl)carbamate (5) To a solution of silyl ether 4 (1.84 g, 3.32 mmol, 1.00 eq.) in dry THF (35 mL) was added TBAF (1 M in THF, 3.98 mL, 3.98 mmoL, 1.20 eq.) at 0°C. The ice bath was removed and the reaction mixture was stirred at rt for 30 min. After the addition of H 2 O (50 mL) and brine (50 mL), the aqueous layer was extracted with EtOAc (5 x 50 mL). The combined organic phases were washed with brine (25 mL), dried (MgSO 4 ) and the solvents were removed under reduced pressure. The residue was purified by column chromatography on silica gel (CyH:EtOAc, 2:1 v/v) to give 5 (1.46 g, 3.31 mmol, quant.) as a colourless, waxy solid. 
Chemical synthesis of ω-azido-sphingosine (2S,3R,E)-2-Amino-18-azidooctadec-4-ene-1,3-diol / ω-azido-sphingosine (6)
To a solution of carbamate 5 (900 mg, 2.04 mmol) in CH 2 Cl 2 (20 mL) was added TFA (4.72 mL) at 0°C. The reaction mixture was stirred at 0°C for 2 h and subsequently treated with H 2 O (100 mL) and 1 M aq. NaOH (100 mL). After the extraction with EtOAc (10 x 50 mL), the combined organic phases were washed with brine (10 mL), dried (MgSO 4 ) and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel (CH 2 Cl 2 :MeOH, 9:1 v/v) to give 6 (423 mg, 1.24 mmol, 61 %) as a colourless, waxy solid. Immunofluorescence of livers (a) and spleens (b) from wild-type (WT) mice that were pretreated with control-liposomes and WT mice that were pretreated with clodronate-liposomes (day -3), infected with 6×10 6 tissue culture infection dose 50 (TCID 50 ) HSV-1 and analyzed after 24 h (n = 3, blue represents Hoechst staining, scale bar 100 µm). c: Immunofluorescence of livers from WT mice that were pretreated with clodronateliposomes (day -3), infected with 8×10 7 TCID 50 HSV-1 and analyzed after 1 h (n = 3, blue represents Hoechst staining, scale bar 100 µm).
Supplementary Figure 2: Herpes simplex virus type 1 (HSV-1) infection of primary fibroblasts
Representative electron microscopy images of wild-type (WT) fibroblasts infected with HSV-1 (MOI 250) analyzed after 30 minutes (n = 106 images from three independent experiments, scale bar 5 µm). Detail shows HSV-1 close to the nucleus. Table 2 : Membrane-modulating proteins in macrophages vs fibroblasts Membrane-modulating proteins from the families of sphingolipids (including gangliosides), cholesterol and phosphatidylcholine which were considered for simplified comparison of macrophages and fibroblasts.
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